Stay updated on AK002 in Allergic Conjunctivitis Clinical Trial
Sign up to get notified when there's something new on the AK002 in Allergic Conjunctivitis Clinical Trial page.

Latest updates to the AK002 in Allergic Conjunctivitis Clinical Trial page
- Check5 days agoChange DetectedAdded a Locations section listing California, Florida, Maryland, Massachusetts, Missouri, New Jersey, and Pennsylvania, and removed the corresponding state location sections. Footer revision note updated to Revision: v3.3.3 with v3.3.2 removed.SummaryDifference1.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedPage revision updated from v3.2.0 to v3.3.2 on the study page, a minor metadata change that does not alter trial information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check41 days agoChange DetectedThe government funding status notice has been removed from the page. All study details, locations, and contacts remain unchanged.SummaryDifference0.4%

- Check55 days agoChange DetectedCore study details for NCT03379311 appear unchanged between versions, including AK002 intervention, eligibility criteria, locations, enrollment, and timelines. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check84 days agoChange DetectedSummary of changes: updated operating-status notice and a version bump to v3.2.0, replacing the previous v3.1.0.SummaryDifference4%

- Check91 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

Stay in the know with updates to AK002 in Allergic Conjunctivitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK002 in Allergic Conjunctivitis Clinical Trial page.